Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure
The request puts Miromatrix on the path for Phase I IND submission and an in-human trial in 2H2022EDEN PRAIRIE, Minn.,...
News
Passage Bio Announces Positive Interim Safety and Biomarker Data and Advances Phase 1/2 Trial of PBGM01 in GM1 Gangliosidosis
– Independent Data Monitoring Committee recommends proceeding with two additional planned patient cohorts, which are now being recruited in parallel...
Medicenna Receives Regulatory Clearance to Expand the Phase 1/2 ABILITY Study of MDNA11 to Canada
-- ABILITY Study is currently ongoing at clinical trial sites in Australia and previously received FDA clearance to expand to...
Gritstone Announces Changes to Its Board of Directors
-- Clare Fisher, accomplished corporate and business development executive and current svp of business development and mergers & acquisitions at...
COMPASS Selected for Addition to NASDAQ Biotechnology Index
London, U.K., Dec. 17, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to...
ObsEva Announces Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
-European Commission Decision Anticipated in Q1 2022- -CHMP recommendation follows the recent acceptance of the linzagolix uterine fibroids NDA by...
Update on Regulatory Submission for Aducanumab in the European Union
Biogen to seek re-examination following CHMP negative opinion for aducanumabCAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq:...
The Ensign Group, Inc. Increases Quarterly Dividend to $0.055 Per Share
SAN JUAN CAPISTRANO, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of...
LIDDS patent covering the NanoZolid® production process granted in China
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on the NanoZolid® production process, and...
Aino Health AB (publ): Transcom expands Aino HealthManager to the Netherlands
Tanscom chooses to expand HealthManager as a SaaS solution to support managers and increase productivity and well-being among their employees.Transcom...
EssilorLuxottica : EssilorLuxottica and GrandVision enter into an agreement with Vision Group for the sale of stores in Italy
EssilorLuxottica and GrandVision enter into an agreementwith Vision Group for the sale of stores in Italy Charenton-le-Pont, France, Schiphol, The...
On heels of global strategic partnership announced today, GENFIT acquires rights to novel asset
Exclusive rights for a novel early-stage asset acquired from Genoscience Pharma in cholangiocarcinoma in the United States, Canada and EuropePhase...
Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891
Phase 1 study in patients with advanced solid tumors planned to start in the first quarter of 2022Ad hoc announcement...
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis,...
Hyloris Enters into Strategic Partnership with Vaneltix for Treatment of Acute Pain in Interstitial Cystitis
Access to AlenuraTM, a dual mode-of-action advanced clinical candidate for the treatment of acute pain in interstitial cystitis/bladder pain syndrome...
ObsEva Announces Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
-European Commission Decision Anticipated in Q1 2022- -CHMP recommendation follows the recent acceptance of the linzagolix uterine fibroids NDA by...
Addex Raises $10.0 Million in Equity Financing
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and...
Sequana Medical to Attend 11th Annual LifeSci Partners Corporate Access Event and H.C. Wainwright BIOCONNECT Virtual Conference
CEO Ian Crosbie to participate in a panel discussion on “MedTech and digital tools: What is the Mindset for 2022?”GHENT, Belgium,...
Extendicare Announces December 2021 Dividend of C$0.04 per Share
MARKHAM, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Bioasis Announces Annual General Meeting Results
NEW HAVEN, Conn., Dec. 16, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical...
